Subscribe to RSS
DOI: 10.1055/s-2007-963199
© Georg Thieme Verlag KG Stuttgart · New York
„Tot oder lebendig?”: Wie und warum myokardiale Vitalitätsdiagnostik mit MRT funktioniert
“Dead or Alive?”: How and Why Myocardial Viability Imaging by Cardiac MRI WorksPublication History
eingereicht: 23.1.2007
angenommen: 26.4.2007
Publication Date:
26 June 2007 (online)

Zusammenfassung
Die Myokardiale Vitalitätsdiagnostik mittels kontrastverstärkter MRT hat in den letzten Jahren stark zur breiten klinischen Akzeptanz der MRT des Herzens beigetragen. Mit der Late-enhancement-Technik steht offensichtlich ein einfaches und robustes Verfahren zur Verfügung, das zuverlässig Myokardnarben als solche identifiziert und quantifiziert. Bei Patienten mit akutem Infarkt lassen sich damit wichtige Aussagen über die Prognose von linksventrikulären Veränderungen und kardialen Ereignissen treffen. Bei Patienten mit KHK und chronischem Infarkt lässt sich anhand des Ausmaßes von Late enhancement zuverlässig die Wahrscheinlichkeit einer regionalen und globalen linksventrikulären Funktionsverbesserung nach erfolgter Revaskularisation voraussagen. Von dieser Untersuchung profitieren insbesondere Patienten mit stark eingeschränkter linksventrikulärer Funktion vor Bypass-OP. Die vorliegende Übersicht beschreibt Definitionen und Physiologie vitalen und avitalen Myokards und die pathophysiologischen Grundlagen des Late enhancements. Der Untersuchungsgang vom richtigen Untersuchungsprotokoll über die Interpretation des Late enhancements im Bild zur korrekten Diagnose und Abschätzung der Vitalität wird beschrieben. Die Hintergründe des Erfolgswegs der Late-enhancement-Methode zur neuen Standardtechnik in der myokardialen Vitalitätsdiagnostik können so nachvollzogen werden.
Abstract
Myocardial viability imaging by contrast-enhanced MRI has supported the broad acceptance of cardiac MRI as a valuable clinical tool in cardiology over the last few years. The late enhancement (delayed enhancement, late gadolinium enhancement) technique has emerged as an easy-to-perform and robust method for identifying and quantifying myocardial scars. In the condition of acute myocardial infarction, MRI offers important prognostic information regarding anticipated left ventricular changes (”remodeling”) and future cardiac events. In coronary artery disease patients with chronic infarction, the extent of late enhancement reliably predicts the outcome of global and regional left ventricular function after revascularization. In particular, CAD patients with severely impaired left ventricular function benefit from preoperative viability imaging before bypass surgery. The present paper describes the definitions and physiology of viable and non-viable myocardium as well as the pathophysiologic basis of late enhancement. The process from the correct setting of imaging protocols via the interpretation of late enhancement images to the stating of the correct diagnosis and estimation of viability is followed. The background of the successful development of the late enhancement method towards the new reference standard in myocardial viability imaging is described.
Key words
heart - tissue characterization - gadolinium - MR imaging
Literatur
- 1
Gropler R J, Bergmann S R.
Myocardial viability - what is the definition?.
J Nucl Med.
1991;
32
10-12
MissingFormLabel
- 2
Kloner R A, Przyklenk K.
Hibernation and stunning of the myocardium.
N Engl J Med.
1991;
325
1877-1879
MissingFormLabel
- 3
Braunwald E, Kloner R A.
The stunned myocardium: prolonged, postischemic ventricular dysfunction.
Circulation.
1982;
66
1146-1149
MissingFormLabel
- 4
Rahimtoola S H.
The hibernating myocardium.
Am Heart J.
1989;
117
211-221
MissingFormLabel
- 5
Baer F M, Voth E, Schneider C A. et al .
Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron
emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary
artery disease. A functional and morphological approach to the detection of residual
myocardial viability.
Circulation.
1995;
91
1006-1015
MissingFormLabel
- 6
Sklenar J, Ismail S, Villanueva F S. et al .
Dobutamine echocardiography for determining the extent of myocardial salvage after
reperfusion. An experimental evaluation.
Circulation.
1994;
90
1502-1512
MissingFormLabel
- 7
Baer F M, Theissen P, Schneider C A. et al .
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically
dysfunctional myocardium after successful revascularization.
J Am Coll Cardiol.
1998;
31
1040-1048
MissingFormLabel
- 8
Wellnhofer E, Olariu A, Klein C. et al .
Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for
the prediction of functional recovery.
Circulation.
2004;
109
2172-2174
MissingFormLabel
- 9
Baumgartner H, Porenta G, Lau Y K. et al .
Assessment of myocardial viability by dobutamine echocardiography, positron emission
tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts.
J Am Coll Cardiol.
1998;
32
1701-1708
MissingFormLabel
- 10
Barkhausen J, Ruehm S G, Goyen M. et al .
MR evaluation of ventricular function: true fast imaging with steady-state precession
versus fast low-angle shot cine MR imaging: feasibility study.
Radiology.
2001;
219
264-269
MissingFormLabel
- 11
Carr J C, Simonetti O, Bundy J. et al .
Cine MR angiography of the heart with segmented true fast imaging with steady-state
precession.
Radiology.
2001;
219
828-834
MissingFormLabel
- 12
Cerqueira M D, Weissman N J, Dilsizian V. et al .
Standardized myocardial segmentation and nomenclature for tomographic imaging of the
heart: a statement for healthcare professionals from the Cardiac Imaging Committee
of the Council on Clinical Cardiology of the American Heart Association.
Circulation.
2002;
105
539-542
MissingFormLabel
- 13
Edelman R R.
Contrast-enhanced MR imaging of the heart: overview of the literature.
Radiology.
2004;
232
653-668
MissingFormLabel
- 14
Hendel R C, Patel M R, Kramer C M. et al .
ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed
tomography and cardiac magnetic resonance imaging: a report of the American College
of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria
Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography,
Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology,
North American Society for Cardiac Imaging, Society for Cardiovascular Angiography
and Interventions, and Society of Interventional Radiology.
J Am Coll Cardiol.
2006;
48
1475-1497
MissingFormLabel
- 15
Rehr R B, Peshock R M, Malloy C R. et al .
Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous
paramagnetic contrast agent administration.
Am J Cardiol.
1986;
57
864-868
MissingFormLabel
- 16
Saeed M, Wendland M F, Watzinger N. et al .
MR contrast media for myocardial viability, microvascular integrity and perfusion.
Eur J Radiol.
2000;
34
179-195
MissingFormLabel
- 17
Inoue S, Murakami Y, Ochiai K. et al .
The contributory role of interstitial water in Gd-DTPA-enhanced MRI in myocardial
infarction.
J Magn Reson Imaging.
1999;
9
215-219
MissingFormLabel
- 18
Hillenbrand H B, Kim R J, Parker M A. et al .
Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging.
Circulation.
2000;
102
1678-1683
MissingFormLabel
- 19
Simonetti O P, Kim R J, Fieno D S. et al .
An improved MR imaging technique for the visualization of myocardial infarction.
Radiology.
2001;
218
215-223
MissingFormLabel
- 20
Mahnken A H, Gunther R W, Krombach G.
Kontrastangehobene MRT und MSCT zur kardialen Vitalitätsdiagnostik.
Fortschr Röntgenstr.
2006;
178
771-780
MissingFormLabel
- 21
Niendorf T, Sodickson D.
Beschleunigung der kardiovaskulären MRT mittels paralleler Bildgebung: Grundlagen,
praktische Aspekte, klinische Anwendungen und Perspektiven.
Fortschr Röntgenstr.
2006;
178
15-30
MissingFormLabel
- 22
Kellman P, Arai A E, McVeigh E R. et al .
Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed
hyperenhancement.
Magn Reson Med.
2002;
47
372-383
MissingFormLabel
- 23
Huber A M, Schoenberg S O, Hayes C. et al .
Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction.
Radiology.
2005;
237
854-860
MissingFormLabel
- 24
Petersen S E, Mohrs O K, Horstick G. et al .
Influence of contrast agent dose and image acquisition timing on the quantitative
determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic
resonance imaging.
J Cardiovasc Magn Reson.
2004;
6
541-548
MissingFormLabel
- 25
Choi S I, Jiang C Z, Lim K H. et al .
Application of breath-hold T2-weighted, first-pass perfusion and gadolinium-enhanced
T1-weighted MR imaging for assessment of myocardial viability in a pig model.
J Magn Reson Imaging.
2000;
11
476-480
MissingFormLabel
- 26
Rochitte C E, Lima J A, Bluemke D A. et al .
Magnitude and time course of microvascular obstruction and tissue injury after acute
myocardial infarction.
Circulation.
1998;
98
1006-1014
MissingFormLabel
- 27
Beek A M, Kuhl H P, Bondarenko O. et al .
Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional
functional improvement after acute myocardial infarction.
J Am Coll Cardiol.
2003;
42
895-901
MissingFormLabel
- 28
Lima J A, Judd R M, Bazille A. et al .
Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced
MRI. Potential mechanisms.
Circulation.
1995;
92
1117-1125
MissingFormLabel
- 29
Wu K C, Zerhouni E A, Judd R M. et al .
Prognostic significance of microvascular obstruction by magnetic resonance imaging
in patients with acute myocardial infarction.
Circulation.
1998;
97
765-772
MissingFormLabel
- 30
Sandstede J J, Beer M, Lipke C. et al .
Time course of contrast enhancement patterns after Gd-BOPTA in correlation to myocardial
infarction and viability: a feasibility study.
J Magn Reson Imaging.
2001;
14
789-794
MissingFormLabel
- 31
Bouchard A, Reeves R C, Cranney G. et al .
Assessment of myocardial infarct size by means of T2-weighted 1H nuclear magnetic
resonance imaging.
Am Heart J.
1989;
117
281-289
MissingFormLabel
- 32
Stork A, Muellerleile K, Bansmann P M. et al .
Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate
between acute and chronic myocardial infarction.
Eur Radiol.
2007;
17
610-617
MissingFormLabel
- 33
Abdel-Aty H, Zagrosek A, Schulz-Menger J. et al .
Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate
acute from chronic myocardial infarction.
Circulation.
2004;
109
2411-2416
MissingFormLabel
- 34
Aletras A H, Tilak G S, Natanzon A. et al .
Retrospective determination of the area at risk for reperfused acute myocardial infarction
with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement
encoding with stimulated echoes (DENSE) functional validations.
Circulation.
2006;
113
1865-1870
MissingFormLabel
- 35
Kim R J, Fieno D S, Parrish T B. et al .
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age,
and contractile function.
Circulation.
1999;
100
1992-2002
MissingFormLabel
- 36
Bulow H, Klein C, Kuehn I. et al .
Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement
signal in patients with chronic coronary artery disease.
Heart.
2005;
91
1158-1163
MissingFormLabel
- 37
Hunold P, Schlosser T, Vogt F M. et al .
Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between
infarction scar and non-infarction-related disease.
Am J Roentgenol.
2005;
184
1420-1426
MissingFormLabel
- 38
Bogaert J, Dymarkowski S.
Delayed contrast-enhanced MRI: use in myocardial viability assessment and other cardiac
pathology.
Eur Radiol.
2005;
15
B52-58
MissingFormLabel
- 39
Stork A, Mullerleile K, Bansmann P M. et al .
Muster der späten Kontrastmittelanreicherung in der MRT bei ischämischen und nicht-ischämischen
Kardiomyopathien.
Fortschr Röntgenstr.
2007;
179
21-30
MissingFormLabel
- 40
Dendale P, Franken P R, Block P. et al .
Contrast enhanced and functional magnetic resonance imaging for the detection of viable
myocardium after infarction.
Am Heart J.
1998;
135
875-880
MissingFormLabel
- 41
Kim R J, Wu E, Rafael A. et al .
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial
dysfunction.
N Engl J Med.
2000;
343
1445-1453
MissingFormLabel
- 42
Bove C M, DiMaria J M, Voros S. et al .
Dobutamine response and myocardial infarct transmurality: functional improvement after
coronary artery bypass grafting - initial experience.
Radiology.
2006;
240
835-841
MissingFormLabel
- 43
Hunold P, Brandt-Mainz K, Freudenberg L. et al .
Myokardiale Vitalitätsdiagnostik mit kontrastverstärkter Magnetresonanztomographie
- Vergleich des „late enhancement”-Konzepts mit der Positronen-Emissions-Tomographie.
Fortschr Röntgenstr.
2002;
174
867-873
MissingFormLabel
- 44
Klein C, Nekolla S G, Bengel F M. et al .
Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging:
comparison with positron emission tomography.
Circulation.
2002;
105
162-167
MissingFormLabel
- 45
Ramani K, Judd R M, Holly T A. et al .
Contrast magnetic resonance imaging in the assessment of myocardial viability in patients
with stable coronary artery disease and left ventricular dysfunction.
Circulation.
1998;
98
2687-2694
MissingFormLabel
- 46
Gerber B L, Rochitte C E, Bluemke D A. et al .
Relation between Gd-DTPA contrast enhancement and regional inotropic response in the
periphery and center of myocardial infarction.
Circulation.
2001;
104
998-1004
MissingFormLabel
- 47
Barkhausen J, Hunold P, Eggebrecht H. et al .
Detection and characterization of intracardiac thrombi on MR imaging.
Am J Roentgenol.
2002;
179
1539-1544
MissingFormLabel
- 48
Ladd S C, Zenge M, Antoch G. et al .
MR-Ganzkörperdiagnostik.
Fortschr Röntgenstr.
2006;
178
763-770
MissingFormLabel
- 49
Fenchel M, Jost D, Kramer U. et al .
Kardiovaskuläre MR-Ganzkörperbildgebung bei Patienten mit symptomatischer Atherosklerose
der peripheren Gefäße.
Fortschr Röntgenstr.
2006;
178
491-499
MissingFormLabel
Dr. Peter Hunold
Institut für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Universitätsklinikum
Essen, Universität Duisburg-Essen
Hufelandstraße 55
45122 Essen
Phone: ++49/2 01/72 38 45 91
Fax: ++49/2 01/7 23 15 48
Email: peter.hunold@uk-essen.de